Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DDB1 | Q16531 | 8/20 | 0.44 |
| ▸ | CRBN | Q96SW2 | 8/20 | 0.44 |
| ▸ | GPR119 | Q8TDV5 | 4/20 | 0.41 |
| ▸ | CHEK2 | O96017 | 2/20 | 0.41 |
| ▸ | ALOX5AP | P20292 | 2/20 | 0.39 |
| ▸ | FEN1 | P39748 | 2/20 | 0.39 |
| ▸ | IDO1 | P14902 | 1/20 | 0.39 |
| ▸ | TDO2 | P48775 | 1/20 | 0.39 |
| ▸ | SLC2A1 | P11166 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25141584 | 0.80 | DDB1 (0.53) | DDB1CRBN | |
| SCHEMBL25141606 | 0.80 | DDB1 (0.46) | DDB1CRBNGPR119 | |
| SCHEMBL31331010 | 0.80 | CRBN (0.53) | DDB1CRBN | |
| SCHEMBL31073232 | 0.79 | CRBN (0.46) | DDB1CRBNGPR119 | |
| SCHEMBL31330777 | 0.78 | IDO1 (0.49) | GPR119CHEK2ALOX5APFEN1IDO1 | |
| SCHEMBL31330808 | 0.78 | CRBN (0.41) | DDB1CRBNGPR119CHEK2ALOX5AP | |
| SCHEMBL31073284 | 0.78 | JAK1 (0.45) | DDB1CRBNGPR119 | |
| Hydrochloric Acid SCHEMBL31330885 | 0.77 | SLC6A2 (0.46) | DDB1CRBN | |
| SCHEMBL24861081 | 0.77 | CRBN (0.53) | DDB1CRBN | |
| SCHEMBL25141804 | 0.75 | DDB1 (0.53) | DDB1CRBNGPR119 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025011623-A1 | CYANOQUINOLINE-TARGETING PROTEIN DEGRADATION MOLECULE, PREPARATION METHOD THEREFOR AND USE THEREOF | 上海壹迪生物技术有限公司 | 2025-01-16 | — | — | WO | disclosed |